O
ISSUER//CIK 0001012140
ONYX PHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A10.1 KBONYX PHARMACEUTICALS INCSep 10, 9:46 AM ET·0000315066-13-003914
- SC 13G35.3 KBONYX PHARMACEUTICALS INCJan 29, 12:36 PM ET·0000019617-13-000149
- 8-K70.9 KBONYX PHARMACEUTICALS INCSep 27, 3:06 PM ET·0001104659-12-065871
- 48.6 KBONYX PHARMACEUTICALS INCAug 28, 5:58 PM ET·0001209191-12-043475
- 8-K12.4 KBONYX PHARMACEUTICALS INCOct 27, 6:10 AM ET·0001193125-11-282917
- 8-K27.5 KBONYX PHARMACEUTICALS INCMay 27, 5:08 PM ET·0000950123-11-055053
- 47.0 KBONYX PHARMACEUTICALS INCApr 4, 8:35 PM ET·0001209191-11-021317
- 49.1 KBONYX PHARMACEUTICALS INCApr 4, 8:26 PM ET·0001209191-11-021305
- 10-Q463.6 KBONYX PHARMACEUTICALS INCMay 4, 4:26 PM ET·0000950123-10-043584
- 8-K84.3 KBONYX PHARMACEUTICALS INCMay 4, 4:17 PM ET·0000950123-10-043568
Insiders
10- Batlin Judy AVP, Org Learning, Dvlpmnt & HR
- Brege LauraEVP and Chief Business Officer
- COLES N ANTHONYDirector, President & CEO
- Foster-Cheek Kaye ISVP, Global Human Resources
- FREEMAN SCOTT MVP, Clinical Research
- FUCHS HENRY JEVP & Chief Medical Officer
- Fust Matthew KChief Financial Officer
- GIOTTA GREGORY JVP & Chief Legal Counsel
- GODDARD PAULDirector
- GRILLO LOPEZ ANTONIO JDirector
Tickers
No tickers on record
Addresses
business
249 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA, 94080
mailing
249 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA, 94080